Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone. - Charbonnel,B.; Karasik,A.; Liu,J. (Diabetes Care, 2006)